V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006607 | 200011881 | 1.79 | 81.8 | null | 2018-02-17 | 2018-03-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100544391 |
| 200006609 | 200011883 | 1.83 | 74 | Palliative (P) | 2015-03-16 | 2015-04-06 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101342687 |
| 200006611 | 200011885 | 1.6 | 88 | Adjuvant (A) | 2016-08-16 | 2016-10-18 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100452809 |
| 200006612 | 200011886 | null | 80 | Palliative (P) | 2019-10-14 | 2019-10-15 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100570987 |
| 200006618 | 200011891 | null | null | null | 2018-03-18 | 2018-03-20 | null | 02 | null | TRIAL UNSPECIFIED | 101280252 |
| 200006620 | 200011893 | 1.75 | 68.8 | Palliative (P) | 2017-08-08 | 2017-10-17 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100540967 |
| 200006621 | 200011894 | 1.65 | 69.2 | Palliative (P) | 2018-06-07 | 2018-06-14 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100736553 |
| 200006623 | 200011896 | 1.8 | 115 | Palliative (P) | 2017-10-14 | 2017-10-14 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100360376 |
| 200006627 | 200011899 | 1.78 | 120 | Palliative (P) | 2019-06-06 | 2019-06-07 | null | N | N | IPILIMUMAB + NIVOLUMAB | 101400110 |
| 200006632 | 200011904 | null | null | null | null | 2016-07-27 | null | null | null | DACARBAZINE | 100981730 |
| 200006635 | 200011907 | null | 70 | Palliative (P) | 2017-03-03 | 2017-03-17 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100559967 |
| 200006636 | 200011908 | null | 59.2 | Palliative (P) | 2016-11-29 | 2016-12-01 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 100894967 |
| 200006637 | 200011909 | null | null | null | null | 2016-06-23 | null | null | null | TRIAL | 101640934 |
| 200006641 | 200011912 | null | 70.6 | 03 | 2017-03-28 | 2017-03-28 | Ipilimumab | 02 | N | IPILIMUMAB | 100971608 |
| 200006648 | 200011919 | 1.71 | 59.1 | Palliative (P) | 2016-11-09 | 2016-11-13 | DABRAFENIB | 02 | null | DABRAFENIB | 101274541 |
| 200006650 | 200011921 | 1.73 | 52.8 | Palliative (P) | 2018-07-30 | 2018-08-05 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100416346 |
| 200006655 | 200011926 | 0 | 0 | Palliative (P) | 2022-01-28 | 2022-02-09 | DABRAFENIB | 02 | null | DABRAFENIB | 100942466 |
| 200006656 | 200011927 | null | 87.3 | null | 2018-05-21 | 2018-05-27 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100784247 |
| 200006658 | 200011929 | 1.64 | 70.8 | Palliative (P) | 2019-06-16 | 2019-06-17 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100651153 |
| 200006659 | 200011930 | 1.69 | 49 | Palliative (P) | 2017-05-12 | 2018-05-28 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101070865 |
| 200006660 | 200011931 | 1.76 | 75 | Palliative (P) | 2018-05-28 | 2018-06-26 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100083832 |
| 200006661 | 200011932 | null | 80.9 | null | 2017-09-12 | 2017-10-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100201762 |
| 200006663 | 200011934 | 1.51 | 65.7 | Adjuvant (A) | 2018-12-29 | 2021-06-03 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100220763 |
| 200006664 | 200011935 | 1.84 | 67.5 | Palliative (P) | null | 2019-10-20 | DABRAFENIB | 01 | null | TRIAL UNSPECIFIED | 100283346 |
| 200006665 | 200011936 | 1.82 | 56 | Palliative (P) | null | 2019-07-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101430706 |
| 200006668 | 200011938 | 1.66 | 94.7 | Palliative (P) | 2020-04-06 | 2020-04-09 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101787593 |
| 200006669 | 200011939 | null | 98.8 | Palliative (P) | null | 2020-12-23 | null | null | null | FLUOROURACIL | 101313147 |
| 200006674 | 200011943 | 1.81 | 80 | Palliative (P) | 2019-04-18 | 2019-05-06 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100152506 |
| 200006677 | 200011946 | null | null | null | null | 2017-07-05 | null | null | null | LOMUSTINE | 101092135 |
| 200006679 | 200011948 | 1.72 | 67.4 | Palliative (P) | 2018-07-29 | 2018-08-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101412384 |
| 200006680 | 200011949 | 1.65 | 94.4 | Palliative (P) | 2017-10-24 | 2017-10-25 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100349554 |
| 200006681 | 200011950 | null | 61.3 | Palliative (P) | 2016-09-06 | 2016-09-13 | Ipilimumab | 02 | null | IPILIMUMAB | 100521096 |
| 200006682 | 200011951 | 1.65 | 65.6 | Palliative (P) | 2017-07-06 | 2017-07-06 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101836818 |
| 200006683 | 200011952 | 1.62 | 82.1 | null | 2016-07-06 | 2016-08-07 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100121217 |
| 200006684 | 200011953 | 1.64 | 91 | null | 2019-12-02 | 2021-02-02 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101007932 |
| 200006685 | 200011954 | null | 76.2 | Palliative (P) | 2018-12-15 | 2018-12-30 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101812707 |
| 200006687 | 200011956 | 1.77 | 77.8 | Palliative (P) | 2020-09-16 | 2020-10-13 | DABRAFENIB | 02 | null | DABRAFENIB | 101363096 |
| 200006688 | 200011957 | 1.58 | 120 | null | 2016-12-02 | 2016-12-21 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101136617 |
| 200006689 | 200011958 | 1.6 | 62 | Palliative (P) | 2018-07-08 | 2018-07-08 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100208212 |
| 200006690 | 200011959 | 1.58 | 95.4 | Palliative (P) | 2018-04-25 | 2018-08-14 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101401823 |
| 200006692 | 200011961 | 1.81 | 78 | Palliative (P) | 2016-05-17 | 2016-05-18 | null | 02 | null | TRIAL UNSPECIFIED | 101321760 |
| 200006693 | 200011962 | 1.77 | 84 | 03 | 2018-09-19 | 2018-10-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101524783 |
| 200006694 | 200011963 | 1.71 | 67 | Palliative (P) | 2019-11-04 | 2019-11-04 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101109236 |
| 200006696 | 200011965 | 0 | 78.5 | Palliative (P) | 2019-05-25 | 2019-05-30 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101128351 |
| 200006699 | 200011968 | null | 88.3 | null | 2016-06-22 | 2016-08-13 | DABRAFENIB | 02 | null | IPILIMUMAB | 101433039 |
| 200006700 | 200011969 | null | 76.4 | Palliative (P) | 2018-02-26 | 2018-03-08 | DABRAFENIB | 02 | N | DABRAFENIB | 101181550 |
| 200006701 | 200011970 | 1.96 | 83.2 | null | 2018-01-17 | 2018-02-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100327522 |
| 200006702 | 200011971 | null | 56.4 | null | 2019-08-20 | 2019-09-10 | DABRAFENIB | 02 | null | DABRAFENIB | 100263742 |
| 200006705 | 200011974 | 1.57 | 168.8 | Palliative (P) | 2017-04-02 | 2017-04-14 | Ipilimumab | 02 | N | IPILIMUMAB | 100147530 |
| 200006706 | 200011975 | 1.81 | 91 | Palliative (P) | 2018-12-24 | 2019-01-06 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100211559 |